Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,024 | 12,823 | 16,075 | 10,258 | 8,460 |
| Marketable Securities | 105,740 | 58,455 | 57,282 | 123,055 | 94,234 |
| Receivables | 30,205 | N/A | N/A | 393 | 1,156 |
| TOTAL | $148,691 | $72,035 | $74,329 | $134,302 | $104,480 |
| Non-Current Assets | |||||
| PPE Net | 905 | 949 | 1,208 | 1,399 | 1,421 |
| Investments And Advances | 5,997 | 5,011 | 41,263 | 16,561 | 16,262 |
| Other Non-Current Assets | 279 | 160 | 181 | 160 | 160 |
| TOTAL | $7,181 | $6,120 | $42,652 | $18,120 | $17,843 |
| Total Assets | $155,872 | $78,155 | $116,981 | $152,422 | $122,323 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 314 | 522 |
| Accounts payable and accrued liabilities | 671 | 675 | 748 | 909 | 750 |
| Accrued Expenses | 8,645 | 4,819 | 7,442 | 5,649 | 6,267 |
| TOTAL | $38,335 | $5,494 | $8,190 | $6,872 | $11,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 16 | 379 |
| Deferred Revenues | 29,019 | N/A | N/A | N/A | 3,761 |
| Other Non-Current Liabilities | 101 | 154 | 185 | 226 | 298 |
| TOTAL | $67,648 | $154 | $185 | $242 | $677 |
| Total Liabilities | $105,983 | $5,648 | $8,375 | $7,114 | $11,977 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,153 | 44,291 | 43,537 | 43,148 | 36,768 |
| Common Shares | 48 | 44 | 43 | 43 | 36 |
| Retained earnings | -307,059 | -267,096 | -219,791 | -172,862 | -134,189 |
| Other shareholders' equity | -66 | -56 | -86 | 24 | -14 |
| TOTAL | $49,889 | $72,507 | $108,606 | $145,308 | $110,346 |
| Total Liabilities And Equity | $155,872 | $78,155 | $116,981 | $152,422 | $122,323 |